Related Experiment Video
Updated: Jun 2, 2026

07:36
Versatile CO2 Transformations into Complex Products: A One-pot Two-step Strategy
Published on: November 9, 2019
First steps towards a Zn/Co(III)sep-driven P450 BM3 reactor
Liqing Zhao1, Güray Güven, Yin Li
1College of Chemistry and Chemical Engineering, Shenzhen University, Shenzhen, 518060 Guangdong, People's Republic of China.
Applied Microbiology and Biotechnology
|May 13, 2011
Summary
This study developed stable, immobilized cytochrome P450 BM3 mutants for cell-free hydroxylation reactions, using a mediator system as a cost-effective alternative to NAD(P)H. The engineered enzymes demonstrated high operational stability and efficiency in continuous bioconversion processes.
Area of Science:
- Biocatalysis
- Enzyme Engineering
- Chemical Synthesis
Background:
- Cytochrome P450s are valuable hydroxylation catalysts, but their cell-free applications are limited by the high cost of NAD(P)H cofactor regeneration.
- Mediator systems, such as Zn/Co(III)sep, offer a cost-effective alternative cofactor system for P450-catalyzed reactions.
Purpose of the Study:
- To engineer and immobilize cytochrome P450 BM3 mutants for enhanced electron transfer with mediator systems.
- To develop stable and efficient biocatalytic systems for cell-free hydroxylation reactions.
- To explore the synthetic potential of engineered P450 BM3 in continuous flow bioreactors.
Main Methods:
- Engineering of P450 BM3 mutants (M7 and M9) with improved electron transfer kinetics.
- Immobilization of P450 BM3 M7 on DEAE-650S and entrapment with k-carrageenan, zinc dust, and catalase.
- Operational stability assessment of immobilized P450 BM3 M7 over 10 batch cycles.
- Development of a plug flow reactor (PFR) for continuous conversion using P450 BM3 M9.
Main Results:
- Immobilized P450 BM3 M7 retained 76% activity and >80% conversion over 10 batch cycles, demonstrating high operational stability.
- P450 BM3 M9 exhibited a 3-fold higher activity for 3-phenoxytoluene compared to P450 BM3 M7.
- The PFR system using P450 BM3 M9 achieved total turnover numbers (TTNs) over 2,000 during 5 days of continuous operation.
Conclusions:
- Engineered and immobilized P450 BM3 variants, coupled with a mediator system, provide a stable and efficient platform for cell-free hydroxylation.
- The developed continuous flow system demonstrates significant potential for industrial applications in biocatalysis.
- This approach overcomes the limitations of costly cofactor regeneration, enabling more sustainable chemical synthesis.

